Trileptal is a medication with the active ingredient called oxcarbazepine. It is also known by its generic name, oxcarbazepine, and sometimes sold under other brand names. Trileptal is used to treat certain types of seizures in people with epilepsy. It helps to stabilize electrical activity in the brain to prevent seizures.
Trileptal costs between £0.53 and £2.71 per pills. Depending on the size of the pack and the number of tablets inside (30 or 360 mg).
Trileptal contains the active ingredient oxcarbazepine. Oxcarbazepine is classified as an anticonvulsant, primarily used to treat epilepsy. The molecular formula is C15H12N2O2, and it has a molecular weight of 252.27 g/mol.
Oxcarbazepine works by stabilizing neuronal membranes and inhibiting repetitive neuronal firing through blocking voltage-sensitive sodium channels. This reduces the transmission of nerve impulses that cause seizures.
Trileptal is indicated for the treatment of partial seizures, with or without secondary generalized seizures, in adults and children aged 2 years and older. It may be used as monotherapy or as adjunctive therapy.
Trileptal is available in various dosage forms including film-coated tablets, oral suspension, and extended-release tablets. The film-coated tablets come in 150 mg, 300 mg, and 600 mg strengths. The oral suspension is available in a concentration of 300 mg/5 mL.
The usual starting dose for adults is 300 mg twice daily. Dosage adjustments should be based on clinical response and tolerability. The typical maintenance dose ranges from 600 mg to 2400 mg daily, administered in two divided doses. In some cases, doses up to 2400 mg/day may be required.
For children aged 2 to 16 years, the starting dose is 8 to 10 mg/kg/day, divided into two doses. This might be increased weekly by increments of 5 mg/kg/day to a maintenance dose of 30 to 46 mg/kg/day. The dosage should be tailored to the individual patient’s response and tolerability.
Trileptal tablets should be swallowed whole with a sufficient amount of water, and they can be taken with or without food. The oral suspension should be shaken well before use and can be mixed with a small glass of water or taken directly.
Store Trileptal in a cool, dry place at temperatures between 15°C to 30°C (59°F to 86°F). Keep the medication out of reach of children. The oral suspension should not be frozen.
Some common side effects of Trileptal include dizziness, drowsiness, fatigue, coordination difficulties, nausea, vomiting, and headache. These effects are generally mild to moderate and may subside over time as the body adjusts to the medication.
Serious adverse reactions include hyponatremia, skin reactions like Stevens-Johnson syndrome, anaphylactic reactions, and multi-organ hypersensitivity reactions. Prompt medical attention is required if any of these occur.
Trileptal may interact with other medications such as phenytoin, valproic acid, and oral contraceptives. It can decrease the plasma concentrations of hormonal contraceptives, reducing their efficacy. Dose adjustments may be necessary when co-administered with certain other drugs.
In patients with impaired renal function (creatinine clearance < 30 mL/min), the starting dose should be reduced to half of the usual starting dose. Close monitoring is recommended, and dose adjustments should be made based on clinical response and tolerability.
Trileptal is metabolized in the liver. However, dose modifications for mild to moderate hepatic impairment are generally not necessary. Caution is advised in patients with severe hepatic impairment, and clinical monitoring is recommended.
Oxcarbazepine crosses the placenta and may cause harm to a developing fetus. It should only be used during pregnancy if the potential benefits justify the potential risks. Oxcarbazepine and its active metabolites are excreted into breast milk; therefore, a decision should be made whether to discontinue breastfeeding or to discontinue the drug.
In case of an overdose, immediate medical attention is necessary. Symptoms of overdose may include somnolence, dizziness, nausea, vomiting, hyperactivity, and loss of coordination. Treatment should be supportive and symptomatic, with close monitoring of vital signs and cardiac function.
Discontinuation of Trileptal should be done gradually to minimize the risk of increased seizure frequency. A tapering schedule should be followed under the supervision of a healthcare provider, tailored to the individual patient’s clinical status.
Patients should be advised to take Trileptal exactly as prescribed. They should be informed about the potential for dizziness and somnolence, and cautioned against performing activities requiring mental alertness such as driving. Patients should also be educated about recognizing signs of serious side effects, including skin rash or swelling, and advised to seek prompt medical attention if these occur.
Elderly patients may be more susceptible to side effects and may require lower initial doses and slower titration to minimize the risk of adverse reactions. Close monitoring of renal function is recommended, as renal impairment can affect drug clearance.
If a dose is missed, patients should take it as soon as they remember unless it is almost time for the next dose. They should not take two doses at once to make up for a missed dose. Consistency in taking the medication is crucial to maintain effective seizure control.